ConductScience.org, home

Trial · NCT02562768

A Study of LY3154207 in Healthy Participants and Participants With Parkinson's Disease

NCT02562768, Phase 1, Completed, Eli Lilly and Company

3 sourcestrials-2026-11-12-0.4.0

Download JSON
Cite this record

ConductScience Library. A Study of LY3154207 in Healthy Participants and Participants With Parkinson's Disease. Trials, record NCT02562768. Release trials-2026-11-12-0.4.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT02562768

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
A Study of LY3154207 in Healthy Participants and Participants With Parkinson's Disease
NCT number
NCT02562768
Status
Completed
Phases
Phase 1
Enrollment
80 participants, actual
Lead sponsor
Eli Lilly and Company
Conditions
Parkinson's Disease
Interventions
LY3154207, Placebo
First posted
2015-09-29
Last updated
2017-03-21

Source ClinicalTrials.gov

Registered outcomes5

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryNumber of Participants with One or More Serious Adverse Event(s) (SAEs) Considered by the Investigator to be Related to Study Drug AdministrationBaseline through study completion (Day 15) in each part.
SecondaryPlasma (blood) Pharmacokinetics: Area Under the Concentration Curve (AUC) of LY3154207At multiple time points from baseline through day 15 in each part
SecondaryPlasma (blood) Pharmacokinetics: Maximum Concentration (Cmax) of LY3154207At multiple time points from baseline through day 15 in each part
SecondaryPlasma (blood) Pharmacokinetics: Area Under the Concentration Curve (AUC) of LY3154207 after a High-Calorie MealBaseline through 24 hours after administration of study drug on Day 10 in Part A.
SecondaryPlasma (blood) Pharmacokinetics: Maximum Concentration (Cmax) of LY3154207 after a High-Calorie MealBaseline through 24 hours after administration of study drug on Day 10 in Part A.

Outcomes0

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

None in this release.

Results by group0

Each measurement the trial posted, group by group, in the words and numbers it posted.

None in this release.

Participant flow0

How many started, completed or left each group, period by period.

None in this release.

Adverse events0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

None in this release.

Adverse event totals0

The totals the trial posted for each group.

None in this release.

Papers2

The papers the trial lists on ClinicalTrials.gov.

PMIDListed asSource
33029934DERIVEDPubMed
34664427DERIVEDPubMed

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

None in this release.

Tests0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

None in this release.

Data dates

The day each source was copied for this release.

ClinicalTrials.gov
2026-11-12
ClinicalTrials.gov
Results, from AACT
2026-03-23
AACT
NIH grant links
2026-11-13
NIH RePORTER

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT02562768

GET https://conductscience.org/api/trials/v1/NCT02562768/registered